Effects of estrogen replacement therapy on vascular endothelial growth factor expression in choroidal and retinal vasculature

Bratislava Medical Journal

Volumn 111, Issue 9, 2010, Pages 473-476

  Dundar, S O ^a   Ozcura, F ^b   Cetin, E D ^a   Beder, N ^a   Dundar, M ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

^b DUMLUPINAR UNIVERSITY   (Turkey)

Author keywords

Choroid; Estrogen; Retina; Vascular endothelial growth factor

Indexed keywords

ESTRADIOL; VASCULOTROPIN A;

ANIMAL; ARTICLE; BLOOD VESSEL; CHOROID; ESTROGEN THERAPY; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; OVARIECTOMY; RAT; RETINA BLOOD VESSEL; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD VESSELS; CHOROID; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; IMMUNOHISTOCHEMISTRY; OVARIECTOMY; RATS; RATS, WISTAR; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77957959312     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000; 41: 3158-3164
2. Crawford TN, Alfaro DV 3rd, Kerrison JB, Jablon EP. Diabetic retinopathy and angiogenesis. Curr Diabetes Rev 2009; 5: 8-13.
3. Khazaei M, Nematbakhsh M. Serum level of vascular endothelial growth factor is increased by estrogen replacement therapy in normotensive and DOCA-Salt hypertensive ovariectomized rats. Clin Chim Acta 2006; 365: 206-210.
4. Agrawal R, Prelevic G, Conway GS, Payne NN, Ginsburg J, Jacobs HS. Serum vascular endothelial growth factor concentrations in postmenopausal women: the effect of hormone replacement therapy. Fertil Steril2000;73: 56-60.
5. Higgins KJ, Liu S, Abdelrahim M, Yoon K, Vanderlaag K, Porter W, Metz RP, Safe S. Vascular endothelial growth factor receptor-2 expression is induced by 17beta-estradiol in ZR-75 breast cancer cells by estrogen receptor alpha/Spproteins. Endocrinology 2006; 147:3285-3295.
6. Garvin S, Nilsson UW, Huss FR, Kratz G, Dabrosin C. Estradiol increases VEGF in human breast studied by whole-tissue culture. Cell Tissue Res 2006; 325: 245-251.
7. Fujimoto J, Sakaguchi H, Hirose R, Ichigo S, Tamaya T. Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cells. Cancer Lett [1999;] 141:63-71.
8. Lam PM, Yim SF, Briton-Jones C, Chung TK, Haines C. Raloxifene therapy in postmenopausal women is associated with a significant reduction in the concentration of serum vascular endothelial growth factor. Fertil Steril 2004; 81: 393-397.
9. Ruffy MB, Kunnavatana SS, Koch RJ. Effects of tamoxifen on normal-human dermal fibroblasts. Arch Facial Plast Surg 2006; 8: 329-332.
10. McNamara DA, Harmey J, Wang JH, Kay E, Walsh TN, Bouchier-Hayes DJ. Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo. Eur J Surg Oncol 2001; 27: 714-718.
11. Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H, Kobayashi K, Honda Y. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1999; 40: 2122-2129.
12. Tanemura M, Miyamoto N, Mandai M, Kamizuru H, Ooto S, Yasukawa T, Takahashi M, Honda Y. The role of estrogen and estrogen receptorbeta in choroidal neovascularization. Mol Vis 2004; 10: 923-932.
13. Espinosa-Heidmann DG, Marin-Castano ME, Pereira-Simon S, Hernandez EP, Elliot S, Cousins SW. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp Eye Res 2005; 80: 413-423.
14. Schultz KL, Birnbaum AD, Goldstein DA. Ocular disease in pregnancy. Curr Opin Ophthalmol 2005; 16: 308-314.
15. Creasman WT. HRT and women who have had breast or endometrial cancer. J Epidemiol Biostat 1999; 4: 217-220.
16. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003; 48: 257-293.
17. Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ. Incidence of exudative age-related macular degeneration among elderly Americans. Ophthalmology 2003; 110: 1534-1539.
18. Mitchell P, Wang JJ, Foran S, Smith W. Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology 2002; 109: 1092-1097.
19. Miyazaki M, Kiyohara Y, Yoshida A, Iida M, Nose Y, Ishibashi T. The 5-year incidence and risk factors for age-related maculopathy in a general Japanese population: the Hisayama study. Invest Ophthalmol Vis Sci 2005; 46: 1907-1910.
20. van Leeuwen R, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, Klein BE, Vingerling JR, Cumming RG, de Jong PT. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology 2004; 111: 1169-1175.
21. Snow KK, Cote J, Yang W, Davis NJ, Seddon JM. Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol 2002; 134: 842-848.
22. Seitzman RL, Mangione C, Ensrud KE, Cauley JA, Stone KL, Cummings SR, Hochberg MC, Hillier TA, Yu F, Coleman AL. Postmenopausal hormone therapy and age-related maculopathy in older women. Ophthalmic Epidemiol 2008; 15: 308-316.
23. Boekhoorn SS, Vingerling JR, Uitterlinden AG, Van Meurs JB, van Duijn CM, Pols HA, Hofman A, de Jong PT. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007; 48: 1012-1017.
24. Losordo DW, Isner JM. Estrogen and angiogenesis: A review. Arterioscler Thromb Vase Biol 2001; 21: 6-12.
25. Applanat MP, Buteau-Lozano H, Herve MA, Corpet A. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. Adv Exp Med Biol 2008; 617: 437-144.